The cloning of the glutamate-gated ion channels of the brain revealed an unexpected level of complexity: there are many different genes that encode distinct subunits of the receptor/channel complex and an even larger number of possible receptor subunit combinations. Many-nearly all-of these gene products are expressed in the retina, and the questions that we face today are: how are they used and why are there so many? Answers to these questions will be found at several levels. At the level of transcription, we have learned that different sets of subunits are expressed by different retinal neurons. Little is known about the transcriptional control of these genes, so it remains to be determined whether these patterns of expression reflect the need for different gene products in different retinal neurons or whether these patterns of expression reflect the functional constraints of gene expression. Another level of complexity is caused by alternative splicing, and here we report that at least four and possibly all eight of the different NMDAR1 transcripts are present in the mouse retina. The consequences of this alternative splicing are poorly understood, but antibodies directed against the two different possible C-termini of NMDAR1 label many of the same cell types. It is possible that these different splice variants are combined to generate the channels. While immunohistochemistry provides us with a glimpse of the subunit proteins, much remains to be learned about their half-life within a retinal cell, their intracellular trafficking, their regulation at the synapse, and the proteins associated with their cytoplasmic domains. An approach we have taken towards studying the dynamic properties of receptor subunits has been to fuse them to the cDNA encoding the jellyfish Green Fluorescent Protein. This makes it possible to follow functional subunits in transfected cells over time and to begin to measure the mobility of the protein.
Introduction
The past 7 years have produced a tremendous wealth of information concerning the molecular nature of the glutamate receptors [1, 2] . We now know that there are two distinct families, the ionotropic and metabotropic receptors, that have very different structures, functions and pharmacological profiles. Moreover, there are many more genes encoding members of each of these families than was previously suspected. The advances in our understanding of the molecular biology of these receptors has been rapid, producing insights into the structure of the genes that encode them [3, 4] , the transcripts that the genes produce, and the structure/function properties of the proteins [5] [6] [7] [8] . While progress at this level has been rewarding, it has generated many unanswered questions concerning how these receptors are actually used within the context of the nervous system. Answers to such questions will be found when we arrive at a full description of the receptor distribution in a well understood part of the nervous system and develop ways to manipulate the receptors in a controlled fashion.
The retina offers a unique opportunity for understanding the biology of glutamate receptors. It is endowed with an extensive glutamatergic synaptic circuitry, and there is strong evidence that glutamate is the neurotransmitter released by photoreceptors and bipolar cells. It appears that this neurotransmitter is responsible for the vertical transmission of the retina's signal through both the outer and inner plexiform layers [9, 10] . The problem that we now face is to first define the molecular nature of the receptors that detect this signal at each synapse. Then the challenge will be to determine whether it is possible to manipulate these receptors to test hypothesis concerning the function of each synapse and circuit. In the following paper we review what we know to date about the glutamate receptors in the retina as well as the progress made in creating receptors that can be followed and manipulated in defined cells.
Methods

RT-PCR analysis of transcripts
Adult mice (C57-BL6: Jackson Laboratories) were sacrificed and their retinae were removed. The neural retinae were dissected free in Ca 2 + /Mg 2 + free Hanks. The retinae were frozen in liquid nitrogen. RNA was isolated with poly-T ferromagnetic beads (Dynal Dynabeads, Dynal, Lake Success NY). First strand cDNA was generated with avian myeloblastosis virus reverse transcriptase (Promega, Madison, WI) for 60 min at 42°C. This DNA was used as template for PCR reactions.
To detect the presence of exon 5, the N1 splice cassette, we used the primer P1 complimentary to exon 4 (ACTTCACTCCCACCCCTGTCTCCTAC), and P2 directed against exon 6 (CTTCCAGGTCCCGGGCT-TCCATCAG). The upper primer P3 complimentary to exon 18 was AGCCCCTGGAAGCAAAATGTGT, and the lower primer P4, which was complimentary to the 3% end of exon 22, was CCGAGGGATCTGA-GAGGTTGAG. These were used to detect the C1 and C2 splice cassettes. To further amplify the longer splice variants, we used the nested primers P5 complimentary to the 5% end of exon 22 (GGGCGGGCGGGGC-GTCTC), and P6 complimentary to exon 21 (the C1 splice cassette; GTCGGGCTCTGCTCTACCACT-CTT).
Taq polymerase (Promega, Madison, WI) was used for the amplification (5U Taq, 1 mM each primer, 10% DMSO, 0.25 mM dNTPs, 2 mM Mg 2 + , and the manufacturer's recommended buffer). A thermal cycler fitted with a temperature gradient across the annealing block (Robocycler, Stratagene) was used for the PCR. The first cycle was 180 s at 94°C, 90 s at the annealing temperature, and 120 s at 74°C. The next 29 cycles were 60 s at 94°C, 90 s at the annealing temperature, and 120 s at 74°C (all of the reactions presented here can be repeated with an annealing temperature of 56°C). A final 5% step at 74°C was used to polish the product. The products were resolved in 1 -3% agarose gels and visualized with ethidium bromide. To determine what the PCR products actually encoded, the bands were resolved on a low-melt agarose gel, purified with a Qiagen column (Qiagen, Chatsworth, CA), and sequenced using Taq FS DNA polymerase and fluorescentdideoxy terminators in a cycle sequencing method. The DNA fragments were electrophoresed and analyzed using an automated Applied Biosystems 373A stretch DNA sequencer (Applied Biosystems).
Immunohistochemistry
For immunohistochemistry, the live retinae were dissociated following the procedure established by Sarthy and Lam [11] and modified by Huba and Hofmann [12] . The cells were allowed to settle on coverslips coated with poly-L-lysine and fixed (10 min in ice-cold, freshly prepared, 2% paraformaldehyde in PBS). The cells were subsequently washed with PBS, then the blocking solution of 4% normal goat serum and 0.01% Tween 20 in PBS, and finally incubated overnight with antibodies or antisera diluted in PBS with 0.01% Tween 20. The primary antibodies were mAb54.1 directed against all NMDAR1 subunits (diluted 1:500, Pharmingen) as well as antisera directed against both possible C-termini of the NMDAR1 subunits (diluted 1:500, Upstate Biotechnology). A monoclonal antibody to PKC was used to identify rod bipolar cells as described in Greferath et al. [13] . We found that the receptor labeling was sensitive to the amount of detergent used in the diluent and did not use Triton X-100. The following day the cells were washed with 0.01% Tween 20 in PBS and then FITC, Cy2, Texas red, or Cy3-conjugated secondary antibodies were used to localize the immunoreactivity (Jackson ImmunoResearch Laboratories, West Grove, PA).
A cooled CCD camera (Princeton Instruments, Trenton, NJ) was used to acquire images of the fluorescently labeled cells. Constant exposure times (3 s) were set to acquire the data the signal was defined as anything that was at least 50-fold greater than the fluorescence seen in the brightest cell on the coverslip that had not been exposed to primary antibody. The typical values for the bipolar cells were 100-150 times brighter than the control cells and the signal seen in the Mueller cells was as high as 2000 times brighter. The images were resized and the contrast was adjusted with Adobe Photoshop and the figures were composed with Pagemaker (Adobe Systems, Mountain View, CA). Manipulations of the files were confined to creating the montages for the figures as well as lettering them.
Cell transfection
Human embryonic kidney 293 cells (HEK293) were maintained in MEM with Earle's Salts, penicillin/streptomycin and 10% FBS. The calcium phosphate technique was used to transfect the cells with the plasmid pNF2 in six well dishes (Promega, Madison, WI). This plasmid expresses the NMDAR1 subunit with the green fluorescent protein fused to the carboxy terminus of the receptor [14] . Cells were washed extensively with medium on the morning following transfection and passaged in the afternoon onto 35 mm tissue dishes that had a c 1.5 coverslip as part of the bottom surface (MatTek; Ashland, MA). Cells were viewed the day after replating, that is, 2 days after transfection.
Confocal microscopy and photobleaching
HEPES (20 mM) was added to the culture medium and the cells were viewed on a BIORAD MRC 600 confocal laser scanning microscope at room temperature. Excitation wavelength was 488 nm. Images were collected with a 100 × 1.4-na lens and were the kalman average of two scans collected with 10% laser. For photobleaching experiments, four images were typically collected at 20 s intervals prior to bleaching. A small portion of the cell soma (14×zoom) was then exposed to 100% laser for 30 or 45 s. Beginning 30 s after the end of bleaching, images of recovery were collected at 20 s intervals. The acquired time-lapse images were examined in NIH Image v1.61 (W. Rasband, NIH; http://rsb.info.nih.gov/nih-image) as a stack. The average brightness of two small regions of interest was then determined at each time point. One region was centered over the bleached portion of the cell, a second was centered over an unbleached portion. Acquired intensity measurements were transferred to IGOR Pro software (WaveMetrics, Lake Oswego, OR). For each time point the intensity measurement for the unbleached spot was subtracted from the bleached spot intensity. Complete mixing should approach zero difference. The resulting differences were plotted against time postbleaching in seconds and fitted with a single exponential.
Results
The distribution of mRNAs encoding the glutamate receptor subunits in the retina has now been mapped for at least one gene product of each gene in at least one species. In comparing the results of many of these different studies, a general picture begins to emerge with only minor differences between the retinae of different mammals.
GluR 1-4 distribution in the retina
There are four subunits in the mammalian nervous system that can, expressed singly or pair wise, produce a glutamate-gated ion channel with the properties of the AMPA-preferring receptors that have been described in vivo [2] . In situ hybridization studies reveal that the distribution of the receptors is widespread [15] [16] [17] [18] . Transcripts encoding GluR1, 2 and 4 are found throughout the inner nuclear and ganglion cell layers. The distribution of GluR3, however, is more restricted: in the rat it is largely confined to the inner third of the inner nuclear layer and the ganglion cell layer, while in the cat retina, it is found over scatter cells at the outermost edge of the inner nuclear layer as well [17] . This labeling pattern over the outer edge of the inner nuclear layer, in only the cat retina, is consistent with the suggestion that the A-type horizontal cells contain this mRNA because the A-type horizontal cells are found in the cat but not the rat retina [19] .
GluR5 -KA1 and 2 distribution in the retina
There are five subunits that can, if expressed in the correct context, form kainate preferring glutamate receptors. Two additional subunits (l1 and l2) are quite similar structurally to the members of this family, and may be kainate-preferring subunits, but they have not yet been shown to be functional [20, 21] . The distribution of the kainate-preferring receptor subunits is widespread, though the signals produced are generally weaker than those generated by probes to the AMPA receptor subunit family. mRNA encoding GluR5 is largely concentrated in the outer two thirds of the inner nuclear layer, while GluR6, 7, KA1 and KA2 are distributed across the inner nuclear layer and ganglion cell layer [15] [16] [17] [18] . No studies of the expression of the delta subunits have yet been reported, so it is not clear whether these are expressed in the retina.
Beyond the diversity caused by the many different genes that encode the GluRs, there is an additional source of heterogeneity. RNA splicing and editing, create at least two and as many as eight different transcripts for each subunit. In some instances, for example the RNA editing of the Q/R site in GluR2 [22] [23] [24] [25] [26] , this has profound effects on the biophysical properties of the receptor that is produced. To date there have been very few studies of the splice variants present in the retina, so little is known about which cells express which forms.
While some splice variants affect the channel and/or pharmacological properties of the receptors [27] , others have no apparent effect on these properties and are poorly understood. For example, in the C-terminus of GluR2, alternative splice sites in the final coding exon generate two very different C-termini for the protein [25] . These two different splice variants are present in the retina [28] , but little is known about their significance. One possibility is that these different C-termini are bound by different intracellular proteins and are localized at different synapses. Recently a new protein has been cloned and characterized that is thought to bind the C-terminus of some GluRs and could be responsible for stabilizing them at synapses [29] .
Considered as a whole, this body of work on the distribution of GluR mRNAs leads us to several deductions. It appears that more than one type of AMPA or Kainate-preferring receptor is expressed in the retina, that it is unlikely that any one type of subunit is expressed by only one retinal cell type, and finally that it is quite likely that multiple different subunits are expressed by any one cell type. An inference that is often drawn from this data is that this differential distribution is a consequence of functional constraints: different receptor subunits, with different properties, are necessary at different synapses. This remains to be proven. An alternative possibility is that the diversity is due to constraints in transcriptional control. Experiments in other systems have shown that, in some instances, related coding sequences can be safely exchanged between different genes, implying that it is the control of expression, rather than the protein product produced, that is important [30, 31] . It remains to be determined whether the complex patterns of GluR distribution is a reflection of functional differences in the proteins or of constraints at the genomic level.
NMDAR1 and NMDAR2 distribution in the retina
In situ hybridization has demonstrated the presence of mRNAs encoding NMDAR1 throughout the inner nuclear layer and the ganglion cell layer [32 -34] . This is surprising in light of the physiology and pharmacology that has led to the conclusion that NMDA receptors are largely used in the circuitry of the inner retina [9] . NMDAR1 is thought to function only when combined with one of the NMDAR2 subunits, and these too are present in the retina. NMDAR2A is largely restricted to the inner edge of the inner nuclear layer as well as the ganglion cell layer [32 -34] , where it appears to be expressed by cells postsynaptic to bipolar cells. NM-DAR2B is present throughout the inner nuclear and ganglion cell layers in a pattern much like NMDAR1 [32, 34] . The expression of NMDAR2C is slight, and present only transiently during development [35] , while NMDAR2D is present in the inner nuclear and ganglion cell layers.
NMDAR1 splice 6ariants in the retina
An additional source of heterogeneity in the NMDA receptor family are the splice variants that are produced by the NMDAR1 gene. There are nine possible variants that can be produced by the gene which is composed of 22 exons [4] . One splice variant encodes a truncated protein devoid of any transmembrane domains that is unlikely to be functional. The other eight arise from the Fig. 1 . This is a schematic of the 5% end of the NMDAR1 transcript and shows the expected outcomes of a PCR with the primers P1 and P2. used to detect the presence of exon 5.
insertion or deletion of exons 5 and 21 as well as the use of alternate acceptor sites in exon 22. To determine whether these different splice variants are present in the retina, we undertook a series of RT-PCR experiments. Fig. 1 illustrates the strategy that we used to amplify the sequences. The primers P1 and P2 are complimentary to exons 4 and 6, respectively and should produce different length products if exon 5 is present in only some transcripts. Fig. 2 shows that two different products are generated whose size (NR1 1xx = 408 bp, and NR1 0xx = 345 bp) is consistent with both the presence and absence of exon 5. This interpretation was confi- Fig. 2 . The products shown are produced by primers P1 and P2, which represent the presence of both NR1 1xx (408 bp) and NR1 0xx (345 bp) transcripts. Lane 1 is a positive control (NR1 011 ), lane 2 is mRNA amplified from the olfactory bulb as a positive control (both variants are present in the bulb: [64] ). Both expected products are present in lane 2 as well as a higher molecular weight product of unknown sequence, lane 3 contains the products from amplified neural retina, and lanes 4 and 5 are the re-amplified and purified NR1 0XX , NR1 1XX , respectively. Molecular markers are a 123-bp ladder. Present at the bottom of each lane are low molecular weight products that are most likely primer dimers. rmed by sequencing the products. The presence of the sequence encoded by this exon produces a recombinant receptor in which Zn 2 + potentiates the action of glutamate [4] , so these results indicate that the action of Zn 2 + on the NMDA receptors of the retina may occur at only some synapses.
To detect the presence of exons 21 and 22, which encode a contiguous section of the 3% end of the transcript, an upper primer P3 complementary to exon 18 and lower primer P4 complementary to the 66 bp segment immediately 5% of the alternative stop codon were used. These primers should amplify all of the different possible splice variants present at the 3% end (Fig. 3) . Fig. 5A shows that the two shortest possible products NR1 x00 and NR1 x10 are present. Fig. 5B shows the purified bands of NR1 x00 and NR1 x10 that were re-amplified and sequenced for confirmation.
Since the different transcripts share some identical regions of sequence, amplification in PCR can bias towards shorter products due to slight differences in the amplification efficiency. To further test for the existence of PCR products representing NR1 x11 and NR1 x01 , both longer than the PCR products of NR1 x10 and NR1 x00 by greater than 50%, we used an additional set of internal primers. P5 was designed to anneal directly on the C2 splice cassette of the transcript. Thus, a second round P3 and P5 PCR reaction would selectively amplify transcripts NR1 x11 and NR1 x01 , if present. Fig. 4 schematically portrays the theoretical products of a P3/P5 PCR and the location of P5 in relation to P4. The template used in these reactions was the raw PCR product of primers P3 and P4, which could contain copies of NR1 x11 and NR1 x01 in low number. The result was two major products with lengths corresponding to NR1 x11 and NR1 x01 (Fig. 5C ). Through band excision and DNA sequencing, the pres- Fig. 4 . The theoretical products of a P3 +P5 PCR and the location of P5 in relation to P4, are schematically portrayed. The template used in these reactions was the raw PCR product of primers P3 and P4, which presumably contained copies of NR1 x11 and NR1 x01 in low number.
ence of NR1 x01 was confirmed. To isolate NR1 x11 fully, PCR with primers P3 and another internal primer, P6, complimentary to exon 21, was necessary. This resulted in a single product of 324 bp (Fig. 5D ). Sequencing confirmed this is NR1 x11 .
While these results demonstrate that the four different splice variants are present in the retina, it was not possible to determine the relationship between the presence or absence of exon 5 in the different C-terminus variants. This was because the 2.5 kb distance between exons 5 and 22 made it difficult to reproducibly amplify the large amount of sequence between exons 4 and 22. It remains to be determined whether the four different splice variants described here are the maximum number present or if the theoretically possible eight different variants exist in the retina. The functional consequences of the different splice variants are poorly understood, though there is recent evidence that alpha-actinin can bind the region of the C-terminus encoded by exon 21 [36] , and there is some evidence that the C-terminus is involved in receptor clustering [37] . It is possible that this region is involved in the localization of the receptor or its interaction with proteins in the postsynaptic junction.
There are three different antibodies that provide useful tools for probing the expression of the NMDAR1 subunit in the retina. One, a monoclonal antibody, recognizes the extracellular loop of NMDAR1 which is present in all splice variants [38] , while the other two antisera recognize the different C-termini that are produced by the use of the two different splice acceptor sites in exon 22. In preparations of dissociated cells, these antibodies robustly label many, but by no means all, of the cells present (Fig. 6) . The labeling is present throughout the cell and there is a significant amount of cytoplasmic labeling. In this preparation there are intact Mueller cells and there are rod bipolar cells that still retain their long axons and terminals.
Labeling these cells with the monoclonal antibody 54.1 directed against all splice variants of NMDAR1 [38] , or the C-terminus antibodies specific for the two different splice variants, produced a robust labeling of many cell somata both large and small. This labeling was excluded from the nucleus, but was associated with both the cytoplasm and the membrane. The large amount of somata that are positive for both of the C-terminus splice variants suggests that many have both forms of the subunit. There is little indication of 1 and 2) . The product from the P3+ P4 reaction was used as template for the P3+ P5 reaction and this produced the other two longer reaction products generated by NR1 x11 and NR1 x01 (C, lane 1 positive control with NR1 011 , lane 2 contains products amplified from neural retina, lane 3 contains the lower molecular weight product from lane 2 re-amplified for sequencing -it is NR1 x01 ). D shows the product from the P3+ P6 reaction that confirms the identity of NR1 X11 (lane 1 is the positive control NR1 011 , lane 2 contains the product produced by re-amplifying the putative NR1 X11 , with internal primers specific for exon 21). Fig. 6 . Antibodies directed against the NMDAR1 subunit produced a robust labeling of many of the dissociated cells. Two of these cell types were readily identifiable, the Mueller cells and rod bipolar cells. Panels A and B are of these cells labeled with the antisera directed against the C-terminus encoded by NR1 x11 and NR1 X01 . Panels C-F are of similar cells labeled with the antisera specific for NR1 x10 and NR1 X00 . Scale bar on bottom right =1 vm/division. differential distribution of the splice variants within a cell, though few processes of the cells remained.
It is surprising that both the Mueller cells and the rod bipolar cells are positively labeled. In the case of the Mueller cells, all three antibodies directed against different portions and different splice variants of NM-DAR1 labeled the cell. This labeling did not appear to be artifactual caused by association with remnants of one of the plexiform layers for there was labeling in the cytoplasm as well. The labeling of Mueller cells was not uniform, although the labeling was spread throughout the cell, and there was a distinctly larger signal at the vitreal end of the cell. Recently Puro et al. [39] showed that Mueller cells freshly isolated from the human Fig. 7 . To confirm the identity of the rod bipolar cells, PKC was used to label sections of retina, and to double label cells exposed to the NMDAR1 antisera. With confocal microscopy (A), a minor population of what appears to be amacrine cells became apparent (arrows). Their presence indicates that in the mouse retina only cells that are readily recognized as rod bipolar cells, on the basis of their long axons and thick terminals, can be unequivocally identified as rod bipolar cells in dissociated cell preparations (this has also been recently reported by Ueda et al. [65] ). In the double labeling experiments, the PKC positive rod bipolar cells were invariably also labeled by the anti-NMDAR1 antisera (B is PKC labeling, C is NR1 x10 and/or NR1 X00 ).
retina have a functional, though somewhat unusual, NMDA receptor, but the significance of these receptors is poorly understood.
The presence of NMDA receptor subunits on the rod bipolar cell is also difficult to understand. In a previous study, with the monoclonal antibody directed against all of the splice variants (mAb 54.1), we found some evidence for the presence of NMDA R1 in rod bipolar cell [28] . The labeling demonstrated here, with the two antisera directed against the C-terminus, provides additional evidence that these cells express this subunit (Fig. 7) . Recently, one group has reported that the NMDAR2D subunit is also present in this cell [40] . These findings are surprising in light of the evidence that glutamate acts to close channels, via mGluR6 [41, 42] , on these depolarizing bipolar cells [10, 43] . Moreover, recent recordings from rod bipolar cells in a slice preparation produced no evidence of NMDA receptor mediated responses [44] . 
GFP-tagged receptor subunits: following functional subunits in li6ing cells
While in situ hybridization provides insights into the expression patterns of the glutamate receptor transcripts, and antibodies provide a view of the proteins that they produce, both of these techniques are limited in the sense that they cannot be used to study the temporal properties of these receptors in living systems. Very little is known about the turnover of the receptor proteins at a synapse, for example, and estimates of the half-life of one of these proteins vary widely [45] . In an attempt to create a receptor subunit that could be followed in living cells, we created a series of constructs in which the Green Fluorescent Protein cloned from the jellyfish was fused to the sequence encoding a receptor subunit. One such construct placed the GFP at the C-terminus of NMDAR1, and produced a subunit that functioned as a channel, when co-expressed with NM-DAR2A or 2C, and which was localized to the membrane compartments of the transfected cells [14] .
One method of defining the mobility of fluorescent proteins in living cells is to photobleach a restricted portion of the cell and then follow the recovery of the fluorescence over time. This provides a measurement of the rate at which the pool of protein moves within the cell. Bleaching experiments of GFP expressed in HEK 293 cells reveals that the mobility of the GFP alone is quite rapid. Indeed, it is too quick to capture on the time scale of seconds in which our confocal microscope operates. This is consistent with previous estimates of GFP mobility [46] . The GFP tagged NMDAR1, however, recovers much more slowly. The fluorescent receptor is present in patches on the plasmamembrane and in a large intracellular compartment of what appears to be tubes or sheets of membrane. When these pools are bleached, the recovery occurs slowly over the time frame of minutes (Fig. 8) . Recovery curves varied from cell to cell (n= 4), with time constants that ranged from 69 to 406 s (Fig. 9) . The apparent mobility of the receptor subunit varied significantly across cells, but measurements of any one particular cell were repro-ducible. It remains to be determined whether this movement is due to diffusion of the subunit within the membrane or of the movements of the organelles that contain them, but movies of these cells show a great deal of membrane movement over time. It is possible that the inter-cell variability was caused by differences in the size or shape of the cell. It is possible that some of the recovery could be due to spontaneous recovery of the GFP fluorophore, but this unlikely. Similar measurements of other GFP-tagged proteins in our laboratory (unpublished results), and in others [47 -49] , have produced very different results depending upon the fusion construct.
Discussion
The photobleaching results provide us with an initial estimate of intracellular movements of NMDA receptor subunits in a heterologous expression system. It has been difficult to study the trafficking of membrane proteins in living cells, and photobleach recovery experiments have primarily focused on the surface distribution and mobility of receptors in the plasma membrane [50, 51] . The results presented here demonstrate the feasibility of a new approach to study the trafficking of receptor subunits in cultured cells, but it remains to be determined whether a similar approach can be used to follow receptor subunits in neurons [52] .
While in situ hybridization, immunohistochemistry and GFP labeling have provided us with initial views of the distribution of the receptor subunits in the neural retina, and mobility within HEK 293 cells, a great deal remains to be learned about the function of these subunits within the context of retinal circuitry. The question that we now face is: how can we understand the exact role of these gene products in the development and function of the retina? For example, we have evidence that glutamate receptor subunits are expressed in rod bipolar cells, yet we have no explanation for why they are there. Can we disrupt their function and learn what they do? The approach currently being taken by many groups is to use gene targeting to disrupt individual genes. This strategy was particularly successful in demonstrating the metabotropic glutamate receptor mGluR6 is responsible for the depolarizing bipolar cell's response to glutamate [41, 42, 53, 54] . One reason this strategy was successful, however, was that mGluR6 is only expressed in the retina and its disruption did not affect other portions of the nervous system. In the case of the ionotropic receptors, this strategy has been less successful. Disruption of genes encoding some of the glutamate-gated ion channels has demonstrated that they are critical to the correct development of the nervous system: most mutants do not survive birth and those that do have severely perturbed nervous system function [55, 56] . Moreover, in the retina, there is good evidence that any one particular subunit is expressed by more than one cell type, so the disruption will not be confined to one particular set of retinal synapses.
The targeted deletion of the mGluR6 gene was particularly insightful since the expression of the receptor is confined to one type of bipolar cell. In situ hybridization reveals that the GluR and NMDAR1 subunits are widely expressed, and there is no evidence that any of these subunits are confined to a particular cell type. The disruption of any of these genes would, therefore, have many effects that would be difficult to disentangle. The Cre-loxp system [57, 58] could be used to circumvent this problem by restricting the disruption to a particular cell type, but this may be complicated since it is likely that most retinal cell types express multiple different subunits that normally act in concert but which could continue to function alone.
One possible strategy, which has been used in other systems to study multiple interacting proteins such as the GluR subunits, would be to create dominant-negative constructs. Dominant-negative mutations are those that produce a protein product that interferes with the normal function of the wild-type protein and its associated partners [59] . Several studies of the voltage-and transmitter-gated ion channels have demonstrated that point mutations in the sequence encoding a channel lining domain can produce a dominant-negative mutation. The observation is that when the mutants are co-expressed with the wild type subunits, no functional channel is formed. Mutations of this sort have been useful in characterizing the structure and function of channels in heterologous expression systems [60] . Recently two dominant mutations in channel subunits have been identified in mice. The 'wea6er' mutation is in the channel lining domain of a potassium channel, GIRK2 [61] , and this single amino acid substitution disrupts the function of the channel causing the wellstudied failure of cerebellar granule cells to migrate to their correct position within the cerebellum. The 'lurcher' mutation appears to be a gain-of-function change to the delta2-type glutamate receptor subunit which produces a constitutively active channel [20, 21] . Dominant-negative mutations have been identified for several of the glutamate-gated ion channels. A mutation in GluR3 (M 611R) produces a glutamate receptor subunit that does not work when expressed alone and which ruins the receptors formed by this subunit in combination with the other GluR subunits 1 through 4 [7] . Now that a number of dominant-negative mutations in channel subunits have been identified, it should be possible to express a mutant channel subunit in a few neurons by using cell-type-specific promoter/ enhancer regions that have been previously identified. The result should be the removal of one class of channels from a few neurons, similar to what occurs in 'wea6er' or 'lurcher'. In this sort of experiment, however, it will be critical to identify exactly which neurons express the mutant protein and when. This might be possible by tagging the dominant-negative construct with GFP, although the use of GFP as a reporter in transgenic mice has only recently been successful [62, 63] and it is difficult to determine whether the GFP signal will be detectable when weaker promoters are used.
